Financials

Ideas Discussions Technicals Seasonals

GBLX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

GB Sciences, Inc. is a biopharmaceutical research and development company, which engages in creating patented, disease-targeted formulations of cannabis, and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The company was founded on April 4, 2001, and is headquartered in Las Vegas, NV.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

GBLX has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company